nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—trigeminal nerve—multiple sclerosis	0.11	0.282	CbGeAlD
Vapreotide—TACR1—peripheral nervous system—multiple sclerosis	0.0515	0.132	CbGeAlD
Vapreotide—SSTR5—brainstem—multiple sclerosis	0.0403	0.103	CbGeAlD
Vapreotide—TACR1—nerve—multiple sclerosis	0.0402	0.103	CbGeAlD
Vapreotide—SSTR2—brainstem—multiple sclerosis	0.026	0.0665	CbGeAlD
Vapreotide—SSTR5—cerebellum—multiple sclerosis	0.0199	0.0509	CbGeAlD
Vapreotide—TACR1—brainstem—multiple sclerosis	0.0172	0.0442	CbGeAlD
Vapreotide—SSTR2—nervous system—multiple sclerosis	0.0136	0.0348	CbGeAlD
Vapreotide—SSTR2—central nervous system—multiple sclerosis	0.0131	0.0335	CbGeAlD
Vapreotide—SSTR2—cerebellum—multiple sclerosis	0.0128	0.0328	CbGeAlD
Vapreotide—TACR1—spinal cord—multiple sclerosis	0.0107	0.0275	CbGeAlD
Vapreotide—SSTR2—brain—multiple sclerosis	0.0104	0.0266	CbGeAlD
Vapreotide—TACR1—nervous system—multiple sclerosis	0.00904	0.0231	CbGeAlD
Vapreotide—TACR1—central nervous system—multiple sclerosis	0.0087	0.0223	CbGeAlD
Vapreotide—TACR1—brain—multiple sclerosis	0.00691	0.0177	CbGeAlD
Vapreotide—SSTR5—GPCR downstream signaling—CCR1—multiple sclerosis	0.0013	0.00213	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL13—multiple sclerosis	0.0013	0.00213	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IFNG—multiple sclerosis	0.00129	0.00212	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—GPR65—multiple sclerosis	0.00129	0.00212	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00128	0.00211	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00128	0.0021	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CNR1—multiple sclerosis	0.00126	0.00207	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—RGS1—multiple sclerosis	0.00126	0.00206	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00125	0.00206	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LINGO1—multiple sclerosis	0.00125	0.00205	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—POMC—multiple sclerosis	0.00123	0.00202	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL10—multiple sclerosis	0.00123	0.00202	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.0012	0.00197	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR1—multiple sclerosis	0.0012	0.00197	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GPR65—multiple sclerosis	0.00119	0.00195	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL3—multiple sclerosis	0.00119	0.00195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL13—multiple sclerosis	0.00118	0.00194	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR1—multiple sclerosis	0.00118	0.00194	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00118	0.00193	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.00117	0.00192	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00116	0.00191	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00116	0.0019	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL1B—multiple sclerosis	0.00115	0.00189	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LINGO1—multiple sclerosis	0.00115	0.00189	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL2—multiple sclerosis	0.00115	0.00189	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—PTGER4—multiple sclerosis	0.00115	0.00188	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—POMC—multiple sclerosis	0.00114	0.00187	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL10—multiple sclerosis	0.00114	0.00186	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCR3—multiple sclerosis	0.00111	0.00182	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00109	0.00179	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR1—multiple sclerosis	0.00109	0.00179	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00109	0.00179	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MMP9—multiple sclerosis	0.00109	0.00178	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TAGAP—multiple sclerosis	0.00108	0.00178	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCR2—multiple sclerosis	0.00108	0.00177	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00106	0.00174	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL5—multiple sclerosis	0.00106	0.00174	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00104	0.0017	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GPR65—multiple sclerosis	0.00103	0.00169	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00101	0.00166	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TAGAP—multiple sclerosis	0.000999	0.00164	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CNR1—multiple sclerosis	0.000994	0.00163	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—RGS1—multiple sclerosis	0.000989	0.00162	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00098	0.00161	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL5—multiple sclerosis	0.000978	0.0016	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000959	0.00157	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCR5—multiple sclerosis	0.000955	0.00157	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—S1PR1—multiple sclerosis	0.000946	0.00155	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000945	0.00155	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000945	0.00155	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GPR65—multiple sclerosis	0.000938	0.00154	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000923	0.00151	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GPC5—multiple sclerosis	0.00092	0.00151	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000911	0.00149	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LINGO1—multiple sclerosis	0.000907	0.00149	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000905	0.00148	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MYC—multiple sclerosis	0.000899	0.00147	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TGFB1—multiple sclerosis	0.000896	0.00147	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000895	0.00147	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000892	0.00146	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000885	0.00145	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCR5—multiple sclerosis	0.000882	0.00145	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MAPK1—multiple sclerosis	0.000879	0.00144	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—S1PR1—multiple sclerosis	0.000873	0.00143	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000861	0.00141	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR1—multiple sclerosis	0.000858	0.00141	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000858	0.00141	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000855	0.0014	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.00085	0.00139	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GPC5—multiple sclerosis	0.000849	0.00139	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL3—multiple sclerosis	0.000841	0.00138	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR2—multiple sclerosis	0.000838	0.00137	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—multiple sclerosis	0.000837	0.00137	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000823	0.00135	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PTGER4—multiple sclerosis	0.00081	0.00133	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RGS1—multiple sclerosis	0.000804	0.00132	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000795	0.0013	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TAGAP—multiple sclerosis	0.000786	0.00129	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCR3—multiple sclerosis	0.000782	0.00128	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL3—multiple sclerosis	0.000776	0.00127	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000773	0.00127	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CNR1—multiple sclerosis	0.000773	0.00127	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL5—multiple sclerosis	0.00077	0.00126	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GPR65—multiple sclerosis	0.000762	0.00125	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR2—multiple sclerosis	0.000761	0.00125	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000747	0.00123	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—POMC—multiple sclerosis	0.000747	0.00122	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RGS1—multiple sclerosis	0.000742	0.00122	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL2—multiple sclerosis	0.00073	0.0012	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000722	0.00118	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000713	0.00117	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000712	0.00117	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GPR65—multiple sclerosis	0.000704	0.00115	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR2—multiple sclerosis	0.000702	0.00115	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CNR1—multiple sclerosis	0.000702	0.00115	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR1—multiple sclerosis	0.000697	0.00114	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL13—multiple sclerosis	0.000697	0.00114	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000697	0.00114	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000696	0.00114	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCR5—multiple sclerosis	0.000694	0.00114	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—POMC—multiple sclerosis	0.000689	0.00113	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—S1PR1—multiple sclerosis	0.000687	0.00113	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000686	0.00113	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL6—multiple sclerosis	0.000675	0.00111	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL2—multiple sclerosis	0.000674	0.00111	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.00067	0.0011	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GPC5—multiple sclerosis	0.000669	0.0011	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CNR1—multiple sclerosis	0.000648	0.00106	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000648	0.00106	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL13—multiple sclerosis	0.000644	0.00106	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR1—multiple sclerosis	0.000644	0.00106	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000642	0.00105	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL10—multiple sclerosis	0.000632	0.00104	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000626	0.00103	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL3—multiple sclerosis	0.000611	0.001	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000609	0.000998	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCL5—multiple sclerosis	0.000599	0.000983	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000588	0.000965	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RGS1—multiple sclerosis	0.000584	0.000959	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000583	0.000957	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000568	0.000932	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000562	0.000921	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GPR65—multiple sclerosis	0.000554	0.000909	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000553	0.000907	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR2—multiple sclerosis	0.000553	0.000907	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL5—multiple sclerosis	0.000544	0.000892	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000544	0.000892	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—POMC—multiple sclerosis	0.000542	0.00089	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.00054	0.000886	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR5—multiple sclerosis	0.00054	0.000885	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000532	0.000873	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL2—multiple sclerosis	0.000531	0.000871	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CNR1—multiple sclerosis	0.00051	0.000837	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR1—multiple sclerosis	0.000507	0.000831	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL13—multiple sclerosis	0.000507	0.000831	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000506	0.00083	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL5—multiple sclerosis	0.000502	0.000824	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000498	0.000817	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL3—multiple sclerosis	0.000497	0.000815	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000491	0.000805	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR5—multiple sclerosis	0.00049	0.000804	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2RA—multiple sclerosis	0.000483	0.000792	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTGER4—multiple sclerosis	0.000478	0.000785	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PGR—multiple sclerosis	0.000471	0.000773	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCR3—multiple sclerosis	0.000462	0.000758	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000459	0.000753	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL3—multiple sclerosis	0.000459	0.000752	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CD28—multiple sclerosis	0.000458	0.000751	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR5—multiple sclerosis	0.000452	0.000742	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR2—multiple sclerosis	0.000449	0.000737	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000446	0.000731	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTGER4—multiple sclerosis	0.000441	0.000724	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000435	0.000714	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PGR—multiple sclerosis	0.000435	0.000713	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCR3—multiple sclerosis	0.000426	0.000699	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CD28—multiple sclerosis	0.000422	0.000693	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—POMC—multiple sclerosis	0.000422	0.000692	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000418	0.000686	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CNR1—multiple sclerosis	0.000415	0.00068	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR2—multiple sclerosis	0.000415	0.00068	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL5—multiple sclerosis	0.000395	0.000648	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000392	0.000643	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—POMC—multiple sclerosis	0.000389	0.000639	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000387	0.000634	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—POMC—multiple sclerosis	0.000383	0.000628	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CNR1—multiple sclerosis	0.000383	0.000628	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL2—multiple sclerosis	0.000375	0.000615	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL10—multiple sclerosis	0.000373	0.000612	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL3—multiple sclerosis	0.000361	0.000592	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR5—multiple sclerosis	0.000356	0.000584	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—POMC—multiple sclerosis	0.000354	0.00058	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000351	0.000576	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTGER4—multiple sclerosis	0.000348	0.00057	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL2—multiple sclerosis	0.000346	0.000567	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL10—multiple sclerosis	0.000345	0.000565	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PGR—multiple sclerosis	0.000342	0.000561	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TYK2—multiple sclerosis	0.00034	0.000558	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCR3—multiple sclerosis	0.000336	0.000551	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CD28—multiple sclerosis	0.000332	0.000545	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR2—multiple sclerosis	0.000327	0.000536	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CD86—multiple sclerosis	0.000327	0.000536	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL5—multiple sclerosis	0.000321	0.000527	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TYK2—multiple sclerosis	0.000314	0.000515	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2—multiple sclerosis	0.000312	0.000512	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—POMC—multiple sclerosis	0.000307	0.000503	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CNR1—multiple sclerosis	0.000301	0.000494	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CD86—multiple sclerosis	0.000301	0.000494	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SPP1—multiple sclerosis	0.000298	0.000488	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL5—multiple sclerosis	0.000297	0.000487	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR5—multiple sclerosis	0.00029	0.000475	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2—multiple sclerosis	0.000288	0.000472	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2RA—multiple sclerosis	0.000285	0.000468	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2—multiple sclerosis	0.000283	0.000465	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—POMC—multiple sclerosis	0.000278	0.000457	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SPP1—multiple sclerosis	0.000275	0.000451	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL2—multiple sclerosis	0.000272	0.000447	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL10—multiple sclerosis	0.000271	0.000445	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR5—multiple sclerosis	0.000267	0.000438	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOE—multiple sclerosis	0.000263	0.000432	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2RA—multiple sclerosis	0.000263	0.000432	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2—multiple sclerosis	0.000261	0.000429	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TYK2—multiple sclerosis	0.000247	0.000406	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOE—multiple sclerosis	0.000243	0.000399	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CD80—multiple sclerosis	0.000238	0.000391	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CD86—multiple sclerosis	0.000237	0.000389	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL5—multiple sclerosis	0.000234	0.000383	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2—multiple sclerosis	0.000227	0.000372	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—POMC—multiple sclerosis	0.000226	0.000371	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL2—multiple sclerosis	0.000221	0.000363	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CD80—multiple sclerosis	0.00022	0.000361	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MAPK1—multiple sclerosis	0.000217	0.000355	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SPP1—multiple sclerosis	0.000216	0.000355	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR5—multiple sclerosis	0.00021	0.000345	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—POMC—multiple sclerosis	0.000209	0.000343	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2RA—multiple sclerosis	0.000207	0.00034	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2—multiple sclerosis	0.000206	0.000338	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL2—multiple sclerosis	0.000204	0.000335	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TYK2—multiple sclerosis	0.000201	0.00033	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MAPK1—multiple sclerosis	0.0002	0.000328	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOE—multiple sclerosis	0.000191	0.000314	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TYK2—multiple sclerosis	0.000186	0.000304	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CD80—multiple sclerosis	0.000173	0.000284	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2—multiple sclerosis	0.000167	0.000274	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—multiple sclerosis	0.000166	0.000273	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—POMC—multiple sclerosis	0.000164	0.00027	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL2—multiple sclerosis	0.000161	0.000264	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—multiple sclerosis	0.000158	0.00026	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000157	0.000258	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2—multiple sclerosis	0.000154	0.000253	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—multiple sclerosis	0.000154	0.000252	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—multiple sclerosis	0.000146	0.00024	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TYK2—multiple sclerosis	0.000146	0.00024	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT3—multiple sclerosis	0.000141	0.000231	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—multiple sclerosis	0.000131	0.000215	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—multiple sclerosis	0.000131	0.000214	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT3—multiple sclerosis	0.00013	0.000213	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK1—multiple sclerosis	0.000128	0.00021	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2—multiple sclerosis	0.000122	0.000199	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—multiple sclerosis	0.000121	0.000198	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—multiple sclerosis	0.000121	0.000198	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—multiple sclerosis	0.00012	0.000198	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK1—multiple sclerosis	0.000118	0.000194	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—multiple sclerosis	0.000115	0.000189	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT3—multiple sclerosis	0.000102	0.000168	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—multiple sclerosis	9.83e-05	0.000161	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—multiple sclerosis	9.51e-05	0.000156	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—multiple sclerosis	9.48e-05	0.000156	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK1—multiple sclerosis	9.3e-05	0.000153	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—multiple sclerosis	9.08e-05	0.000149	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—multiple sclerosis	7.15e-05	0.000117	CbGpPWpGaD
